covaxin
-
Covid-19
Covaxin, Corbevax get nod for 5-12 years
New Delhi, April 26 (UNI): Bharat Biotech’s Covaxin has been approved for being administered to children between 6 and 12…
Read More » -
Covid-19
Covaxin, Covishield receive regulator nod for conditional market authorisation
New Delhi, Jan 27 (UNI): Two Covid-19 vaccines, Covaxin by Bharat Biotech and Covishield by the Serum Institute of India,…
Read More » -
Covid-19
Covaxin booster dose neutralises Omicron & Delta variants
New Delhi, Jan 12: Bharat Biotech said on Wednesday that Covaxin has the potential to neutralise SARS-CoV-2 variants, including Omicron.…
Read More » -
Covid-19
Over 3 lakh children registered on Day 1 of Covid vaccination
New Delhi, Jan 2 (UNI): More than 3 lakh children enrolled for Covid vaccination as the Co-WIN portal opened for…
Read More » -
Covid-19
India sends 500,000 doses of Covaxin to Afghanistan
New Delhi, Jan 1 (UNI): India on Saturday supplied 500,000 doses of Covid-19 vaccine Covaxin to Afghanistan, and will be…
Read More » -
Covid-19
WHO authorises Bharat Biotech’s Covaxin for emergency use
Shillong, Nov 4: Bharat Biotech, a global leader in vaccine development and innovation, has announced that Covaxin, India’s first indigenous…
Read More » -
Covid-19
50 cr Indians get first dose of vaccine
New Delhi, Sept 1 (UNI): After 50 crore people in the country received the first dose of Covid-19 vaccine, Union…
Read More » -
Covid-19
DCGI nod to phase 2-3 clinical trial of Covaxin in 2-18 age group
New Delhi, May 13 (UNI): The Drugs Controller General of India (DCGI) has granted permission to Bharat Biotech Ltd to…
Read More »